Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GNAZ | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | ANXA3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | SUGP1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
mRNA | GABRB2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
mRNA | MCM2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | CSMD3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
mRNA | FAM217A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | ZNF670 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | PTPRN | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | ARL6 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |